AFYREN SAS (EPA:ALAFY)

France · Delayed Price · Currency is EUR

2.750

-0.025 (-0.90%)

Jul 10, 2026, 5:35 PM CET

16.28% (1Y)

Market Cap	98.84M +42.9%
Revenue (ttm)	2.27M -20.6%
Net Income	-14.37M
EPS	-0.53
Shares Out	35.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,531
Open	2.820
Previous Close	2.775
Day's Range	2.750 - 2.820
52-Week Range	2.065 - 3.235
Beta	0.61
Analysts	Strong Buy
Price Target	4.50 (+63.64%)
Earnings Date	Sep 25, 2026

About AFYREN SAS

AFYREN SAS provides biobased products to replace petroleum-based molecules in France. It offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. The company’s products are used in the flavors and fragrances, lubricants and functional fluids, feed, food, life sciences, and materials science markets. The company was founded in 2012 and is headquartered in Clermont-Ferrand, France. [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 2012

Employees 121

Stock Exchange Euronext Paris

Ticker Symbol ALAFY

Full Company Profile

Financial Performance

In 2025, AFYREN SAS's revenue was 2.27 million, a decrease of -20.58% compared to the previous year's 2.86 million. Losses were -14.37 million, 47.3% more than in 2024.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for ALAFY stock is "Strong Buy." The 12-month stock price target is €4.50, which is an increase of 63.64% from the latest price.

Price Target

€4.50

(63.64% upside)

Analyst Consensus: Strong Buy

Stock Forecasts